MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
31.97
+1.43 (4.68%)
At close: Dec 5, 2025, 4:00 PM EST
31.35
-0.62 (-1.94%)
After-hours: Dec 5, 2025, 7:49 PM EST
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $1.44 billion as of December 5, 2025. Its market cap has increased by 169.49% in one year.
Market Cap
1.44B
Enterprise Value
1.04B
1-Year Change
169.49%
Ranking
Category
Stock Price
$31.97
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has increased from $509.66M to $1.44B, an increase of 181.66%. That is a compound annual growth rate of 132.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.44B | 133.08% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |